Clinical trial
Metabolomics Pilot Study on Postoperative Intensive Care Acquired Muscle Weakness (MIRACLE-I Study)
NCT03810768 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolomics Pilot Study on Postoperative Intensive Care Acquired Muscle Weakness (MIRACLE-I Study)
- Lead sponsor
- Technical University of Munich
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- September 2, 2022
- Completion date
- December 31, 2026
- Enrollment
- 20 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
critical care, critical illness, critical illness myopathy, critical illness polyneuropathy, intensive care (icu) myopathy, metabolomics, muscle weakness